Evidence for safety and efficacy is based on the findings from the eNRGy study
Home World News FDA Approves Zenocutuzumab-zbco for Advanced, Unresectable or Metastatic Cholangiocarcinoma
Evidence for safety and efficacy is based on the findings from the eNRGy study
